Expression of hepatoma‐derived growth factor in hepatocellular carcinoma
Tsung‐Hui Hu(National Sun Yat-sen University), Ming Hong Tai(National Sun Yat-sen University), Chao‐Cheng Huang(Kaohsiung Chang Gung Memorial Hospital), Lifeng Liu(I-Shou University), Chi‐Sin Changchien(Kaohsiung Chang Gung Memorial Hospital), Hsueh‐Wen Chang(National Sun Yat-sen University), Pey‐Ru Lin(Kaohsiung Veterans General Hospital), Shang‐Yun Liu(Chang Gung Memorial Hospital), Chuan‐Mo Lee(Kaohsiung Chang Gung Memorial Hospital), Jiin‐Haur Chuang(Chang Gung University)
Cited by 125
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
|Gastroenterology|2007|232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan
|World Journal of Gastroenterology|2006|217